Please Wait.....
Report
Asia-Pacific Point-of-Care Testing (POCT) Market
Market Report I 2025-04-01 I 350 Pages I Data Bridge Market Research
Asia-Pacific Point-Of-Care Testing (POCT) Market size was valued at USD 20.18 billion 2024 and is projected to reach USD 8.56 billion by 2032, with a CAGR of 11.4% during the forecast period of 2025 to 2032.
Market Segmentation:
Asia-Pacific Point-Of-Care-Testing (POCT) Market, By Product Type (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Monitoring Products, Pregnancy and Fertility Testing Products, Hematology Testing Products ,Coagulation Monitoring Products, Drugs-Of-Abuse (DOA) Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Tumor/Cancer Marker Testing Products, Fecal Occult Testing Products, and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Immunoassays, Dipsticks, Molecular Diagnostics, Clinical Chemistry Assays, Microfluidics, Hematology, and Others), Application (Blood Glucose, Infectious Diseases, Vital Sign Monitoring, Cardiac Monitoring, Coagulation, Haematology, Non- Invasive SpO2 Monitoring, Blood Transfusion, Non- Invasive PCO2 Monitoring, Whole Blood Analysis, and Others), Prescription Mode (Prescription-Based Testing and Over The Counter Testing), End User (Hospitals, Home Care, Clinics, Laboratories, Diagnostic Centers, Pathology Labs, Ambulatory Surgery Centers, Elderly Care Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales, and Others), Country (China, Japan, India, Australia, South Korea, Singapore, Thailand, Philippines, Malaysia, Indonesia, Vietnam, and Rest of Asia-Pacific) - Industry Trends & Forecast To 2032
Overview of the Asia-Pacific point-of-care-testing (POCT) market are:
Driver
- Rising Use of POC Testing In Healthcare Facilities
Restraint
- Data Security and Privacy Concerns
Opportunity
- Rising Awareness and Advocacy for Point-Of-Care Testing
Market Players:
The key market players for Asia-Pacific point-of-care-testing (POC) market are listed below:
- F. Hoffmann-La Roche Ltd
- Danaher Corporation
- Siemens Healthineers AG
- BD (Becton, Dickinson and Company)
- Abbott (U.S.)
- Pfizer Inc.
- Thermo Fisher Scientific Inc.
- BIOMERIEUX
- QIAGEN
- QuidelOrtho Corporation
- Sekisui Diagnostics
- Hologic, Inc.
- Sysmex Corporation
- Meridian Bioscience
TABLE OF CONTENTS
1 INTRODUCTION 191
1.1 OBJECTIVES OF THE STUDY 191
1.2 MARKET DEFINITION 191
1.3 OVERVIEW OF THE ASIA-PACIFIC POINT-OF-CARE-TESTING (POCT) MARKET 191
1.4 CURRENCY AND PRICING 193
1.5 LIMITATIONS 193
1.6 MARKETS COVERED 194
2 MARKET SEGMENTATION 199
2.1 MARKETS COVERED 199
2.2 GEOGRAPHICAL SCOPE 200
2.3 YEARS CONSIDERED FOR THE STUDY 201
2.4 DBMR TRIPOD DATA VALIDATION MODEL 202
2.5 MULTIVARIATE MODELLING 205
2.6 TYPE LIFELINE CURVE 205
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 206
2.8 DBMR MARKET POSITION GRID 207
2.9 MARKET END USER COVERAGE GRID 208
2.10 VENDOR SHARE ANALYSIS 209
2.11 SECONDARY SOURCES 210
2.12 ASSUMPTIONS 210
3 EXECUTIVE SUMMARY 211
4 PREMIUM INSIGHTS 213
4.1 PORTER'S FIVE FORCES 217
4.2 PESTEL ANALYSIS 218
4.3 HEALTHCARE ECONOMY 219
4.3.1 HEALTHCARE EXPENDITURE 219
4.3.2 CAPEX TRENDS 220
4.3.3 CAPEX ALLOCATION 220
4.3.4 FUNDING SOURCES 220
4.3.5 INDUSTRY BENCHMARKS 221
4.3.6 GDP RATIO IN OVERALL GDP 221
4.3.7 HEALTHCARE SYSTEM STRUCTURE 221
4.3.8 GOVERNMENT POLICIES 222
4.3.9 ECONOMIC DEVELOPMENT 222
4.4 MICRO AND MACRO ECONOMIC FACTORS 224
4.5 TECHNOLOGY ROADMAP: ASIA-PACIFIC POINT OF CARE TESTING 226
5 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: REGULATIONS 227
6 MARKET OVERVIEW 230
6.1 DRIVERS 232
6.1.1 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES 232
6.1.2 RISING INCIDENCE OF SUBSTANCE ABUSE 232
6.1.3 INCREASED ADOPTION OF TELEMEDICINE 233
6.1.4 ADVANCEMENTS TECHNOLOGIES ENHANCING POC TESTING WITH BIOSENSORS AND MOBILE INTEGRATION 234
6.2 RESTRAINTS 235
6.2.1 DATA SECURITY AND PRIVACY CONCERNS 235
6.2.2 LACK OF ACCURACY AND TECHNICAL CHALLENGES 235
6.3 OPPORTUNITIES 237
6.3.1 RISING AWARENESS AND ADVOCACY FOR POINT-OF-CARE TESTING 237
6.3.2 STRATEGIC INITIATION AND DECISION TAKEN BY THE MARKET PLAYERS 237
6.3.3 EXPANDING PRODUCT RANGE FOR POINT-OF-CARE TESTING 238
6.4 CHALLENGES 239
6.4.1 LIMITED AWARENESS AND ACCEPTANCE 239
6.4.2 IMPACT OF HIGH MAINTENANCE COSTS THREATEN POINT-OF-CARE TESTING (POCT) SUSTAINABILITY IN LOW-RESOURCE SETTINGS 239
7 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE 241
7.1 OVERVIEW 242
7.2 GLUCOSE MONITORING PRODUCTS 247
7.2.1 STRIPS 248
7.2.2 METERS 248
7.2.3 LANCETS AND LANCING DEVICES 248
7.3 INFECTIOUS DISEASE TESTING PRODUCTS 249
7.3.1 COVID-19 251
7.3.2 HIV TESTING PRODUCTS 251
7.3.2.1 TESTING REAGENTS 251
7.3.2.2 TESTING EQUIPMENT 251
7.3.3 RESPIRATORY INFECTION TESTING PRODUCTS 252
7.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING 252
7.3.4.1 NAAT-BASED SYSTEMS 252
7.3.4.2 NON-NAAT-BASED SYSTEMS 252
7.3.5 HEPATITIS C TESTING PRODUCTS 253
7.3.5.1 HCV ANTIBODY TESTS 253
7.3.5.2 HCV VIRAL LOAD TESTS 253
7.3.6 INFLUENZA TESTING PRODUCTS 254
7.3.6.1 TRADITIONAL DIAGNOSTIC TEST 254
7.3.6.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT) 254
7.3.6.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT) 254
7.3.6.1.3 VIRAL CULTURE 254
7.3.6.1.4 SEROLOGICAL ASSAY 254
7.3.6.2 MOLECULAR DIAGNOSTIC ASSAY 256
7.3.6.2.1 RT-PCR 256
7.3.6.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP) 256
7.3.6.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT) 256
7.3.6.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA) 256
7.3.7 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING 257
7.3.8 TROPICAL DISEASE TESTING PRODUCTS 257
7.3.9 OTHER INFECTIOUS DISEASE TESTING PRODUCTS 257
7.4 CARDIOMETABOLIC MONITORING PRODUCTS 259
7.4.1 CARDIAC MARKER TESTING PRODUCTS 260
7.4.1.1 HSTNL 260
7.4.1.2 BNP 260
7.4.1.3 D-DIMER 260
7.4.1.4 CK-MB 260
7.4.1.5 MYOGLOBIN 260
7.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS 261
7.4.2.1 BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES 262
7.4.2.1.1 CARTRIDGES 262
7.4.2.1.2 REAGENTS 262
7.4.2.2 BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS 263
7.4.2.2.1 PORTABLE 263
7.4.2.2.1.1 COMBINED ANALYZERS 264
7.4.2.2.1.2 BLOOD GAS ANALYZERS 264
7.4.2.2.1.3 ELECTROLYTE ANALYZERS 264
7.4.2.2.2 BENCHTOP 265
7.4.2.2.2.1 Combined Analyzers 265
7.4.2.2.2.2 Blood Gas Analyzers 265
7.4.2.2.2.3 Electrolyte Analyzers 265
7.4.3 HBA1C TESTING PRODUCTS 266
7.4.3.1 HBA1C TESTING INSTRUMENTS 266
7.4.3.2 HBA1C TESTING CONSUMABLES 266
7.4.4 POC ANALYZER 267
7.4.5 ECG DEVICE 268
7.4.5.1 RESTING ECG DEVICES 268
7.4.5.2 STRESS ECG DEVICES 268
7.4.5.3 HOLTER MONITORS 268
7.5 PREGNANCY AND FERTILITY TESTING PRODUCTS 269
7.6 PREGNANCY TESTING PRODUCTS AND FERTILITY TESTING PRODUCTS 270
7.6.1 STRIPS/ DIP STICKS AND CARDS 270
7.6.2 MID STREAM DEVICES 270
7.6.3 CASSETTES 270
7.6.4 DIGITAL DEVICES 270
7.6.5 LINE-INDICATOR DEVICES 270
7.6.6 LUTEINIZING HORMONE (LH) URINE TEST 272
7.6.7 FSH TEST 272
7.6.8 OTHERS 272
7.7 HAEMATOLOGY TESTING PRODUCTS 273
7.8 COAGULATION MONITORING PRODUCTS 274
7.8.1 ANTICOAGULATION MONITORING DEVICES 275
7.8.1.1 PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES 275
7.8.1.2 ACTIVATED CLOTTING TIME (ACT) 275
7.8.1.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT) 275
7.8.2 PLATELET FUNCTION MONITORING DEVICES 276
7.8.3 VISCOELASTIC COAGULATION MONITORING DEVICES 276
7.8.3.1 ROTATIONAL THROMBOELASTOMETRY (ROTEM) 276
7.8.3.2 THROMBOELASTOGRAPHY (TEG) 276
7.9 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS 277
7.9.1 DOA ANALYSERS 278
7.9.1.1 IMMUNOASSAYS 278
7.9.1.2 CHROMATOGRAPHIC DEVICES 278
7.9.1.3 BREATH ANALYSERS 278
7.9.2 RAPID TESTING DEVICES 279
7.9.2.1 URINE TESTING DEVICES 279
7.9.2.2 ORAL FLUID TESTING DEVICES 279
7.9.3 OTHERS 279
7.10 URINALYSIS TESTING PRODUCTS 280
7.10.1 POC URINE STRIP SELF-TESTING 281
7.10.2 POC URINE TEST STRIP PROFESSIONAL TESTING 281
7.11 CHOLESTEROL TESTING PRODUCTS 282
7.11.1 TESTING KITS 283
7.11.2 INSTRUMENTS 283
7.11.2.1 TABLE-TOP ANALYZERS 283
7.11.2.2 HAND-HELD ANALYZERS 283
7.12 TUMOR/CANCER MARKER TESTING PRODUCTS 284
7.13 FECAL OCCULT TESTING PRODUCTS 285
7.13.1 GUAIAC FOB STOOL TEST 286
7.13.2 LATERAL FLOW IMMUNO-FOB TEST 286
7.13.3 IMMUNO-FOB AGGLUTINATION TEST 286
7.13.4 IMMUNO-FOB ELISA TEST 286
7.14 OTHERS 287
8 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 288
8.1 OVERVIEW 289
8.2 OTC TESTING 292
8.3 PRESCRIPTION-BASED TESTING 293
9 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM 294
9.1 OVERVIEW 295
9.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS 299
9.3 IMMUNOASSAYS 300
9.4 DIPSTICKS 300
9.5 MOLECULAR DIAGNOSTICS 301
9.6 CLINICAL CHEMISTRY ASSAYS 301
9.7 MICROFLUIDICS 302
9.8 HEMATOLOGY 302
9.9 OTHERS 303
10 ASIA-PACIFIC POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION 304
10.1 OVERVIEW 305
10.2 BLOOD GLUCOSE 309
10.3 INFECTIOUS DISEASES 309
10.3.1 COVID-19 TESTING 310
10.3.2 HIV TESTING 310
10.3.3 HEPATITIS C TESTING 310
10.3.4 INFLUENZA TESTING 310
10.3.5 TUBERCULOSIS TESTING 310
10.3.6 OTHERS 310
10.4 VITAL SIGN MONITORING 311
10.5 CARDIAC MONITORING 312
10.6 COAGULATION 312
10.7 HAEMATOLOGY 313
10.8 NON- INVASIVE SPO2 MONITORING 313
10.9 BLOOD TRANSFUSION 314
10.10 NON- INVASIVE PCO2 MONITORING 314
10.11 WHOLE BLOOD ANALYSIS 315
10.12 OTHERS 315
11 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 316
11.1 OVERVIEW 317
11.2 HOSPITALS 321
11.2.1 PRIVATE 321
11.2.2 PUBLIC 321
11.2.3 PRIVATE IF FURTHER SUB-SEGMENTED INTO TIER 1, TIER 2 AND TIER 3. 321
11.2.3.1 Tier 1 322
11.2.3.2 Tier 2 322
11.2.3.3 Tier 3 322
11.3 HOME CARE 323
11.4 CLINICS 323
11.5 LABORATORIES 324
11.6 DIAGNOSTIC CENTERS 324
11.7 PATHOLOGY LABS 325
11.8 AMBULATORY SURGERY CENTERS 325
11.9 ELDERLY CARE CENTERS 326
11.10 OTHERS 326
12 ASIA-PACIFIC POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 327
12.1 OVERVIEW 328
12.2 DIRECT TENDER 331
12.3 RETAIL SALES 332
12.4 ONLINE SALES 333
12.5 OTHERS 334
13 ASIA-PACIFIC POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION 335
13.1 ASIA-PACIFIC 337
13.1.1 CHINA 365
13.1.2 JAPAN 391
13.1.3 INDIA 417
13.1.4 SOUTH KOREA 442
13.1.5 AUSTRALIA 467
13.1.6 SINGAPORE 492
13.1.7 MALAYSIA 517
13.1.8 THAILAND 542
13.1.9 INDONESIA 567
13.1.10 PHILIPPINES 594
13.1.11 VIETNAM 619
13.1.12 REST OF ASIA-PACIFIC 644
14 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: COMPANY LANDSCAPE 646
14.1 COMPANY SHARE ANALYSIS: GLOBAL 646
15 SWOT ANALYSIS 647
16 COMPANY PROFILES 648
16.1 F. HOFFMANN-LA ROCHE LTD 648
16.1.1 COMPANY SNAPSHOT 648
16.1.2 REVENUE ANALYSIS 648
16.1.3 COMPANY SHARE ANALYSIS 649
16.1.4 PRODUCT PORTFOLIO 649
16.1.5 RECENT DEVELOPMENT 650
16.2 DANAHER 651
16.2.1 COMPANY SNAPSHOT 651
16.2.2 REVENUE ANALYSIS 651
16.2.3 COMPANY SHARE ANALYSIS 652
16.2.4 PRODUCT PORTFOLIO 652
16.2.5 RECENT DEVELOPMENT 654
16.3 SIEMENS HEALTHINEERS AG 655
16.3.1 COMPANY SNAPSHOT 655
16.3.2 REVENUE ANALYSIS 655
16.3.3 COMPANY SHARE ANALYSIS 656
16.3.4 PRODUCT PORTFOLIO 656
16.3.5 RECENT DEVELOPMENT 657
16.4 BD VERITOR(BD) 657
16.4.1 COMPANY SNAPSHOT 657
16.4.2 REVENUE ANALYSIS 658
16.4.3 COMPANY SHARE ANALYSIS 659
16.4.4 PRODUCT PORTFOLIO 659
16.4.5 RECENT DEVELOPMENT 661
16.5 ABBOTT POINT OF CARE INC(ABBOTT) 663
16.5.1 COMPANY SNAPSHOT 663
16.5.2 REVENUE ANALYSIS 663
16.5.3 COMPANY SHARE ANALYSIS 664
16.5.4 PRODUCT PORTFOLIO 664
16.5.5 RECENT DEVELOPMENT 665
16.6 ACCUBIOTECH CO., LTD. 666
16.6.1 COMPANY SNAPSHOT 666
16.6.2 PRODUCT PORTFOLIO 666
16.6.3 RECENT DEVELOPMENT 679
16.7 ABAXIS (ABAXIS IS A PART OF ZOETIS) 680
16.7.1 COMPANY SNAPSHOT 680
16.7.2 PRODUCT PORTFOLIO 680
16.7.3 RECENT DEVELOPMENT 680
16.8 BINX HEALTH 681
16.8.1 COMPANY SNAPSHOT 681
16.8.2 SOLUTION PORTFOLIO 681
16.8.3 RECENT DEVELOPMENT 682
16.9 BIOMERIEUX 683
16.9.1 COMPANY SNAPSHOT 683
16.9.2 REVENUE ANALYSIS 683
16.9.3 PRODUCT PORTFOLIO 684
16.9.4 RECENT DEVELOPMENT 685
16.10 BIO- RAD LABORATORIES, INC. 686
16.10.1 COMPANY SNAPSHOT 686
16.10.2 PRODUCT PORTFOLIO 686
16.10.3 RECENT DEVELOPMENT 688
16.11 CHEMBIO DIAGNOSTICS, INC. 689
16.11.1 COMPANY SNAPSHOT 689
16.11.2 PRODUCT PORTFOLIO 689
16.11.3 RECENT DEVELOPMENT 690
16.12 EKF DIAGNOSTICS HOLDINGS PLC 691
16.12.1 COMPANY SNAPSHOT 691
16.12.2 PRODUCT PORTFOLIO 691
16.12.3 RECENT DEVELOPMENT 694
16.13 HOLOGIC, INC 695
16.13.1 COMPANY SNAPSHOT 695
16.13.2 REVENUE ANALYSIS 695
16.13.3 PRODUCT PORTFOLIO 696
16.13.4 RECENT DEVELOPMENT 698
16.14 LAMDAGEN CORPORATION 699
16.14.1 COMPANY SNAPSHOT 699
16.14.2 PRODUCT PORTFOLIO 699
16.14.3 RECENT DEVELOPMENT 699
16.15 MERIDIAN BIOSCIENCE 700
16.15.1 COMPANY SNAPSHOT 700
16.15.2 PRODUCT PORTFOLIO 700
16.15.3 RECENT DEVELOPMENT 702
16.16 NOVA BIOMEDICAL 703
16.16.1 COMPANY SNAPSHOT 703
16.16.2 PRODUCT PORTFOLIO 703
16.16.3 RECENT DEVELOPMENT 708
16.17 PFIZER INC. 709
16.17.1 COMPANY SNAPSHOT 709
16.17.2 PRODUCT PORTFOLIO 709
16.17.3 RECENT DEVELOPMENT 710
16.18 PTS DIAGNOSTICS 711
16.18.1 COMPANY SNAPSHOT 711
16.18.2 PRODUCT PORTFOLIO 711
16.18.3 RECENT DEVELOPMENT 712
16.19 QIAGEN 713
16.19.1 COMPANY SNAPSHOT 713
16.19.2 REVENUE ANALYSIS 714
16.19.3 PRODUCT PORTFOLIO 714
16.19.4 RECENT DEVELOPMENT 715
16.20 QUIDELORTHO CORPORATION 716
16.20.1 COMPANY SNAPSHOT 716
16.20.2 REVENUE ANALYSIS 716
16.20.3 PRODUCT PORTFOLIO 717
16.20.4 RECENT DEVELOPMENT 719
16.21 QUANTUMDX GROUP LTD. 720
16.21.1 COMPANY SNAPSHOT 720
16.21.2 PRODUCT PORTFOLIO 720
16.21.3 RECENT DEVELOPMENT 722
16.22 SEKISUI DIAGNOSTICS 723
16.22.1 COMPANY SNAPSHOT 723
16.22.2 PRODUCT PORTFOLIO 723
16.22.3 RECENT. DEVELOPMENT 725
16.23 SIENCO, INC. 726
16.23.1 COMPANY SNAPSHOT 726
16.23.2 PRODUCT PORTFOLIO 726
16.23.3 RECENT UPDATES 727
16.24 SYSMEX CORPORATION 728
16.24.1 COMPANY SNAPSHOT 728
16.24.2 REVENUE ANALYSIS 728
16.24.3 PRODUCT PORTFOLIO 729
16.24.4 RECENT DEVELOPMENT 731
16.25 TRINITY BIOTECH 732
16.25.1 COMPANY SNAPSHOT 732
16.25.2 REVENUE ANALYSIS 732
16.25.3 PR.PRODUCT PORTFOLIO 733
16.25.4 RECENT DEVELOPMENT 733
16.26 TRIVIDIA HEALTH, INC. 734
16.26.1 COMPANY SNAPSHOT 734
16.26.2 PRODUCT PORTFOLIO 734
16.26.3 RECENT UPDATES 736
16.27 THERMO FISHER SCIENTIFIC INC. 737
16.27.1 COMPANY SNAPSHOT 737
16.27.2 REVENUE ANALYSIS 737
16.27.3 PRODUCT PORTFOLIO 738
16.27.4 RECENT DEVELOPMENT 738
16.28 WERFEN 739
16.28.1 COMPANY SNAPSHOT 739
16.28.2 PRODUCT PORTFOLIO 739
16.28.3 RECENT DEVELOPMENT 741
17 QUESTIONNAIRE 742
18 RELATED REPORTS 746
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security